Ginkgo Bioworks Holdings Reports Second Quarter 2023 Net Loss of $173.3 Million
Achieves $80.6 Million in Revenue for Q2 2023
Ginkgo Bioworks Holdings,(DNA) a leading biotechnology compa ny specializing in cell engineering and biosecurity, has announced its financial results for the second quarter of 2023. The company reported a net loss of $173.3 million for the quarter, while achieving a total revenue of $80.6 million. The detailed financial report showcases the company's balance sheets, statements of operations, and cash flows.
Ginkgo Bioworks Holdings Reports Second Quarter 2023 Net Loss of $173.3 Million
Ginkgo Bioworks Holdings, Inc., a trailblazing biotechnology company known for its innovative work in cell engineering and biosecurity, has disclosed its financial performance for the second quarter of 2023. The company revealed a net loss of $173.3 million during this period, reflecting its ongoing investments in research and development initiatives and strategic business expansions.
